GLP-1 Price Tracker: What Changed This Month (May 2026)
Prices verified May 2026 · Compare GLP-1 Editorial Team
Updated: May 2026. We track GLP-1 medication pricing across brand-name and compounded markets monthly. Bookmark this page for the latest.
May 2026 Market Summary
The GLP-1 pricing landscape continues to evolve. Brand-name pricing has seen downward pressure from manufacturer savings programs and increasing insurance coverage. Compounded pricing remains competitive but faces uncertainty from ongoing FDA enforcement. Here's what moved this month.
Brand-Name Pricing
Brand-name retail pricing has been relatively stable. The real action is in savings programs and insurance coverage expansion. Novo Nordisk's NovoCare and Eli Lilly's LillyDirect continue to expand eligibility for manufacturer savings, and more commercial insurance plans are adding GLP-1 weight management coverage.
Compounded Pricing
Compounded semaglutide pricing has remained competitive as the number of telehealth providers continues to grow. Compounded tirzepatide availability is more constrained due to FDA enforcement actions, which has kept prices higher where it's available.
Key Developments to Watch
Orforglipron approval timeline: Eli Lilly's oral GLP-1 agonist could receive FDA approval in 2026–2027. If approved, it could significantly disrupt both brand-name and compounded pricing by offering a convenient, potentially lower-cost oral option.
Medicare coverage: Legislation to extend GLP-1 coverage under Medicare continues to advance. If enacted, this would dramatically expand the addressable market and could put downward pressure on brand-name pricing.
Compounding enforcement: The FDA continues to evaluate compounding regulations. Any significant enforcement changes could rapidly affect compounded medication availability and pricing.
Prices change. This page is updated monthly but may not reflect promotional pricing or short-term offers. Always verify current pricing directly with the provider before committing.
Check Current Pricing
Embody
Injectable semaglutide at transparent, stable pricing.
$149 first month / $299 refills
Check Eligibility → Paid linkCompounded medications are not FDA-approved.
Yucca Health
Among the lowest verified monthly prices for compounded semaglutide.
$146/mo semaglutide (6-month plan)
Check Eligibility → Paid linkCompounded medications are not FDA-approved.
Oak Longevity
Competitive semaglutide pricing.
From $130/mo semaglutide
Check Eligibility → Paid linkCompounded medications are not FDA-approved.